Green Transformational Leadership on Green Creativity: A Quantitative Study Within the Ghanaian Manufacturing Industry ...
Management reaffirmed that the soquelitinib Phase II atopic dermatitis trial will begin in early Q1 2026, enrolling approximately 200 patients across 70 global sites and including those who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback